Grants per year
Personal profile
Research Interests
My primary interests are in developing novel therapeutic combinations for the treatment of gastrointestinal cancers. I am interested in incorporating immunotherapy and molecular testing into clinical trials.
Training Experience
| 2009 | Residency, St. Vincents Hospital, Melbourne Australia |
| 2011 | Residency, University Hospitals Case Medical Center, Cleveland OH |
| 2014 | Fellowship, University of Pittsburgh Medical Center |
| 2014 | Fellowship, Northwestern University |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Medicine, MBBS, Flinders University
… → 2005
Research interests keywords
- Cancer Biology
- Colon / Rectal Cancer
- Nanotechnology
- Pancreatic Cancer
Fingerprint
Dive into the research topics where Aparna Kalyan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prot #CTX‐009‐002: A Phase 2/3 Randomized, Controlled Study of CTX‐009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemi
Kalyan, A. (PD/PI)
Catalyst Clinical Research, LLC, Compass Therapeutics, Inc.
7/18/23 → 7/18/26
Project: Research project
-
Prot #VLS-101-0003/MK-2140-002: A Phase 2 Study of VLS-101 in Patients with Solid Tumors
Kalyan, A. (PD/PI)
3/1/23 → 3/1/26
Project: Research project
-
A Phase 2 study of Savolitinib in Patients with MET Amplified Metastatic Colorectal Cancer
Jia, J., Moyer, A., Lowe, M., Bolch, E., Kortmansky, J., Cho, M., Lenz, H. J., Kalyan, A., Niedzwiecki, D. & Strickler, J. H., Dec 2025, In: Journal of Gastrointestinal Cancer. 56, 1, 29.Research output: Contribution to journal › Article › peer-review
-
A trial of radiolabeled antibody yttrium-90–FF-21101 for the treatment of advanced ovarian and other cancers
Mahalingam, D., Owonikoko, T. K., Delpassand, E., Mulcahy, M. F., Kalyan, A., Ulahannan, S., Cheung, K., Izumi, Y., Johansen, M., Madden, T., Shimoyama, S., Subach, R. A., Suzuki, T., Wages, D. S., Wheeler, C. & Richardson, D. L., Jan 1 2025, In: cancer. 131, 1, e35680.Research output: Contribution to journal › Article › peer-review
Open Access -
Yttrium-90 Radiation Segmentectomy for Treatment of Neuroendocrine Liver Metastases
Gordon, A. C., Savoor, R., Kircher, S. M., Kalyan, A., Benson, A. B., Hohlastos, E., Desai, K. R., Sato, K., Salem, R. & Lewandowski, R. J., Feb 2025, In: Journal of vascular and interventional radiology : JVIR. 36, 2, p. 293-300 8 p.Research output: Contribution to journal › Article › peer-review
-
COMPANION-002 A clinical trial of investigational drug CTX-009 plus paclitaxel vs paclitaxel in second line advanced BTC
Azad, N., Hu, Z., Sahin, I., Iyer, R., Aranha, O., Hochster, H., Pathak, P., Paulson, A. S., Kalyan, A., Liao, C. Y., Tran, N., Kelley, R. K., Heestand, G., Cosgrove, D., El-Khoueiry, A., Borad, M., Gabrail, N. Y., Majeed, U., Du, L. & Kamath, S. & 5 others, , 2024, In: Future Oncology. 20, 30, p. 2241-2248 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Leveraging radiomics and AI for precision diagnosis and prognostication of liver malignancies
Haghshomar, M., Rodrigues, D., Kalyan, A., Velichko, Y. & Borhani, A., 2024, In: Frontiers in Oncology. 14, 1362737.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations